Healthcare Startups funded by Y Combinator (YC) 2026

November 2026

Browse 613 of the top Healthcare startups funded by Y Combinator.

We also have a Startup Directory where you can search through over 5,000 companies.

  • Ginkgo Bioworks
    Ginkgo Bioworks
    Y Combinator LogoS2014
    Public • 641 employees • Boston
    Ginkgo Bioworks is the organism company. We design custom organisms for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.
    synthetic-biology
    automation
    diagnostics
  • Ordo Labs
    Ordo Labs
    Y Combinator LogoF2026
    Active • 4 employees • San Francisco
    Ordo is rebuilding lab software for the AI era. The next generation of lab software will be a workforce scientists direct. We’re building it for regulated labs. Our agents analyze instrument data, apply each lab’s quality rules and draft source-linked reports. We have paid pilots and have cut a 40-hour post-analysis workflow to four hours, including scientist review. Our ambition is for labs to grow their capacity by deploying agents, without multiplying manual work. Agents do the work, scientists sign.
    automation
    biotech
    ai
    compliance
  • BioDelivera
    BioDelivera
    Y Combinator LogoF2026
    Active • 2 employees • San Francisco
    BioDelivera has developed proprietary GCV™, a drug delivery platform designed to travel through the body and selectively target diseased cells while sparing healthy ones. GCVs can carry genetic medicines, DNA, RNA, small molecules, or combinations of these at the same time. BioDelivera has demonstrated efficacy in tumors, muscle, and brain and is expanding to additional tissues. The company’s mission is to enable cures for every patient, across every disease.
    drug-delivery
    gene-therapy
    ai
    therapeutics
    biotechnology
  • Helios Intelligence
    Helios Intelligence
    Y Combinator LogoF2026
    Active • 5 employees • Boston
    Helios is building a molecular body test from a single drop of blood. Our at-home test measures more than 1,000 biomarkers and turns them into a living model of the body—designed to show what is happening now, surface risk earlier, and become more useful with every test. By combining longitudinal molecular data with labs, wearables, health records, and outcomes, we are building toward a world model of human biology. Our goal is to simulate all of human health and use that intelligence to help people perform, recover, and live longer.
    diagnostics
    health-&-wellness
    health-tech
    consumer
    ai
  • Canos
    Canos
    Y Combinator LogoF2026
    Active0 • Oxford, UK
    Canos is bringing a human-grade liquid biopsy platform for dogs, starting with a single blood draw. We sequence cell-free DNA to perform multi-modal analysis of fragmentation, copy number variation, native methylation (5mC and 5hmC) and more to detect cancer signals. Owners bank a healthy baseline for their dog and track changes every year. Dogs already diagnosed get personalized monitoring through treatment. We partner with mobile vets and vet clinics to serve SF and NYC. Our mission is to make pet cancer curable through early detection and monitoring.
    anti-aging
    diagnostics
    biotechnology
  • Kairos Health
    Kairos Health
    Y Combinator LogoF2026
    Active • 4 employees • San Francisco
    Kairos Health automates patient engagement for dentists by handling phones and insurance. Kairos plugs into a dental practice's software, calls patients who are overdue for care, and books them directly into the schedule. It also answers every inbound call 24/7 and verifies insurance. Our mission is to put practice operations on autopilot and keep every chair filled.
    saas
    health-tech
    conversational-ai
  • Altair Health
    Altair Health
    Y Combinator LogoF2026
    Active • 4 employees • Austin, TX, USA
    Altair is an AI-native medical billing service for independent practices. We take over a practice's billing end to end and get doctors paid by insurers. AI does the work; our billers handle the exceptions. That can only work if a practice can trust an agent alone with its revenue. So we formalized insurers' billing policies and put a theorem prover under the agent. Before the agent acts on a claim, the prover checks the action against that insurer's policies, and anything that fails goes to one of our billers. Every claim teaches Altair how each insurer behaves, so the longer we run a practice's billing, the better we predict what its insurers will pay, deny or delay. We're building the default way a new practice gets paid: a doctor connects their EHR and bills clean, completely self-serve and on auto-pilot. Altair will be the financial platform every independent practice in America starts on and stays on. And to the Health Insurers' "Delay, Deny, Defend", we say "Predict, Prevent, Prevail".
    health-tech
    healthcare
    ai
  • Sutrix
    Sutrix
    Y Combinator LogoF2026
    Active • 2 employees • San Francisco
    Sutrix turns messy data from EHRs, clinical notes, wearables, and surveys into clean, study-ready datasets allowing healthcare research teams to deliver tailored patient care faster. Before a clinical study can start, research staff spend weeks pulling patient data from disconnected systems like the EHR, REDCap, and wearable platforms, reading notes chart by chart, and reconciling conflicting entries in spreadsheets. Sutrix automates that work by deploying AI systems within each team’s own environment, linking patient records across sources, applying the study's rules, and flagging unclear cases for staff to review. Paying research teams at 10+ institutions cut data prep by 80% going from months per study to weeks. We're brothers who've built together for 4 years. We first solved this problem doing forward-deployed work at HSS, where we built an injury surveillance system now used by 700+ teams. Ritvik's clinical research at HSS and Emory showed us every research team has the same bottleneck. Supratik previously founded and exited an ai security company backed by a16z Speedrun, and built production AI agents at Amazon.
    healthcare
    healthcare-it
  • Saccade
    Saccade
    Y Combinator LogoF2026
    Active • 2 employees • San Francisco
    Alzheimer's testing today is bottlenecked around the onset of symptoms, when the damage is already done. Current treatments, including the FDA-approved drugs released in 2024, don't reverse the disease; they only slow it down. Earlier detection means earlier intervention. Eye movement changes linked to Alzheimer's surface sooner than any other biomarker, up to 15 years before symptoms appear. We deliver a 15-minute VR assessment delivered to patients in longevity clinics: • Tasks: patients perform visual tasks designed by neurologists to trigger a distinct oculomotor response in people with Alzheimer's or on its path • Hardware: our patent-pending attachment connects to any VR headset on the market and captures these eye movement patterns. • Analysis: the patterns are compared against our ML model to produce a risk analysis. Once classified, patients can access new interventions, such as the FDA-approved drugs. They're also referred to longevity practices, neurology practices or both, depending on their stage of decline. Testing for the earliest biomarkers allows the earliest possible intervention. In some cases, that slows the disease enough that patients outlive the onset of symptoms and never face memory loss in their lifetime.
    healthcare
    hardware
    machine-learning
    hard-tech
    b2b
  • Ascenix
    Ascenix
    Y Combinator LogoF2026
    Active • 7 employees • Toronto, ON, Canada
    Ascenix is building one custom interface for running senior homes. We combine reusable building blocks into workflows tailored to each home's existing processes, from incident reporting to reimbursement. Homes get custom software without hiring an engineering team. Living in a retirement home convinced us that the best way to improve residents' lives is to improve the systems staff rely on. As the older population grows, care teams need more time and resources. Repetitive reporting, missed reimbursement, and compliance problems take those away. Disconnected products that solve each of these individually add costs and leave staff moving information between systems. Our building blocks gather information from EHRs like PointClickCare and other sources, process it, apply rules, and produce reports, tasks, or emails. Incident reporting and reimbursement reviews usually come from two separate vendors. Ascenix builds both from the same blocks, in one interface, so data isn't stuck in silos. Homes start with their biggest bottleneck and add workflows as priorities change.
    digital-health
    healthcare-it
  • Archangel Health
    Archangel Health
    Y Combinator LogoF2026
    Active • 2 employees • San Francisco
    Archangel Health builds the infrastructure to post-train and evaluate medical AI: RL environments inside real de-identified EHRs, physician-verified training data, and benchmarks that test clinical reasoning on hard cases. Frontier labs and medical AI companies use it today, and we're now moving toward post-training open-source models for health systems on their own data and their own physicians' judgment
    health-tech
  • CONUS
    CONUS
    Y Combinator LogoF2026
    Active • 3 employees • Cologne, Germany
    CONUS structures fragmented medical device information for surgeons. We combine manufacturer documentation, hospital protocols and medical research in one place, giving surgeons and MedTech teams reliable answers across products and procedures through search and source-backed AI. We already work with leading manufacturers including Johnson & Johnson, Stryker and Zimmer Biomet, and since launching six months ago we’ve gone live in 27 hospitals, with 49 more onboarding. Long term, hospitals will use CONUS to source and order surgical devices across manufacturers.
    ai
    healthcare
  • Rhem Labs
    Rhem Labs
    Y Combinator LogoF2026
    Active • 2 employees • San Francisco
    Rhem Labs builds smart home care devices that help older adults and people with complex care needs live independently.
    consumer-products
    robotics
    health-&-wellness
  • Nxtcure Labs
    Nxtcure Labs
    Y Combinator LogoF2026
    Active0 • San Francisco
    NxtCure Labs is an AI-native, full-stack CRO built to take therapeutics from discovery to market faster. We are reinventing medicine from lab to drug discovery. About 2 million Americans are diagnosed with cancer every year. Science has never moved faster, new immunotherapies, targeted drugs and cancer vaccines arrive every year. But roughly 90% of cancer drugs fail in clinical trials, and about 80% of trials run late. The breakthroughs exist. The way we test them is stuck in the last century. NxtCure is building autonomous clinical trials. Before a single patient enrolls, we run the trial thousands of times on digital twins. Each virtual patient is a system of coupled differential equations that track how a drug moves through plasma, tumor and heart, and how the tumor grows, shrinks or fights back. The parameters are fit to real trial data, so every twin behaves like real biology. Across thousands of simulations we can calculate the odds that a dose will hit its endpoints, and fix the protocol before it costs anyone time, money or hope. Then 13 AI agents run the trial. Each one owns a stage: drafting the protocol, ranking sites, pre-screening patients, forecasting drug supply, watching for adverse events, predicting dropout, cleaning data and writing the final report. As real data comes in, the twins update and flag problems weeks before a human would see them. In 2025, the FDA laid out how computer simulation can take its place. Soon a cancer drug will run through thousands of simulated trials before it ever touches a lab, and reach patients years faster. We’re building that future.
    healthcare
    health-tech
  • Halmos Labs
    Halmos Labs
    Y Combinator LogoF2026
    Active • 3 employees • Lund, Sweden
    The drug development pipeline is built around humans. Other AI biotech companies build automation around the established infrastructure. Halmos Labs rebuilds the infrastructure around automation. The central bottleneck is access to experiments. Halmos Labs platform physicalvalidation.com connects agents to biolabs across the globe in days rather than weeks. Using physicalvalidation.com, Halmos research agent is continuously designing drugs and has so far designed and tested a new mRNA cancer vaccine and a new antibiotic with results December 10th.
    swarm-ai
    biotech
    ai-powered-drug-discovery
    automation
    auto-commerce
  • Allia Health
    Allia Health
    Y Combinator LogoS2026
    Active • 3 employees • San Francisco
    Allia is the first full-stack, AI-native clinical group for mental health. We bring independent practices into one national clinical group that can deliver, measure, and improve care at scale .
    healthcare
    mental-health
    ai
  • WonderTx
    WonderTx
    Y Combinator LogoS2026
    Active • 3 employees • San Francisco
    We’re an AI-native biotech, working on replacing needles with pills. Many drugs, like insulin or Ozempic, are wonderful except you have to inject them. We discover new molecules that you can take as a pill instead. Because the pills operate on biology which has been shown to be effective in people, rather than merely in animal models of disease, we avoid what has historically been the single biggest risk in drug discovery.  This should dramatically increase our probability of success. There’s $200B of treatable diseases and validated human biology without a pill because discovery programs lack a tractable chemical starting point. This is a zero-shot inference problem, because these targets have no training data, so LLMs and other historical interpolative AI approaches are insufficient. Instead, we are building our own extrapolative frontier models that reason beyond their training data. Most critically, we have repeatedly validated our platform on both our own and partner programs. On 4 biologically- and structurally-diverse targets where we had zero training data, we successfully picked binders that were validated experimentally, with confirmation ranging from primary screen hits to crystallographic structures.
    ai-powered-drug-discovery
    generative-ai
    biotech
  • Evergrove
    Evergrove
    Y Combinator LogoS2026
    Active • 2 employees • New York City
    We've built voice agents for the largest work comp managed care orgs and specialist PT networks in the country, making >500K calls annually and accelerating the speed at which they coordinate care. On average, our customers see a 40% increase in workflow completion, 10x decrease in cycle times, and >60% reduction in cost. We think voice agents are the starting point for solving slow and fragmented care coordination in this market. Companies that manage an injured worker's care rely on short-staffed contact centres and archaic methods of info exchange: phone, fax, and email. Every delay along the path of care leads to slower rehab of the injured worker, lower throughput for providers, and higher expense for the insurer/employer.
    healthcare
    ai
    insurance
  • Radley
    Radley
    Y Combinator LogoS2026
    Active • 2 employees • San Francisco
    Radley is the first AI-native radiology practice. We're acquiring a radiology practice bringing Radley to $4.6M in annualized revenue and rebuilding it with agents from the ground up. Radiology is already in crisis: there aren't enough radiologists to interpret 1 in 6 medical scans. In 10 years, that gap is growing to 1 in 3 - 246M scans a year. From past experience, we know that point solutions won’t cut it. While there is demand (we have $2.2M in contracts to prove it), bottleneck isn't just software, it's outdated systems and slow, inefficient operations. That's why we own the full stack, clinical and operational, end to end. We met at Carbon Health as we scaled operations 31x and expanded to 100+ clinics. Now we're rebuilding radiology.
    healthcare
    b2b
  • Omanta
    Omanta
    Y Combinator LogoS2026
    Active • 6 employees • San Francisco
    Omanta is a personalized research lab for patients who have exhausted standard options, want to prepare proactively for recurrence, or are living with an unresolved diagnosis. We direct the full operational infrastructure, personnel, expertise, and technology of a large research program toward understanding and addressing the challenges of individual patients across oncology, rare disease, and undiagnosed conditions. For clinicians, we act as a collaborative partner, providing a living roadmap for ongoing patient care built on a rigorous and evolving scientific evidence base. We fully operationalize patient-specific research programs, covering tissue logistics, diagnostic follow-up, data integration, multiomic analysis, therapeutic strategy development, and more. Omanta brings context and clarity to complex cases, helping clinicians see more of the scientific picture as they decide how best to care for their patients.
    healthcare
    digital-health
    oncology
    health-&-wellness
    ai
  • Rasyn
    Rasyn
    Y Combinator LogoS2026
    Active • 3 employees • San Francisco
    We build foundational AI models for chemistry. Almost nothing you buy is a single chemical. Products like datacenter coolant, GPU thermal paste, paint, and glue are formulations, which are mixtures of around ten ingredients each, and demand for them has grown quickly because of AI and EVs. Designing a new formulation is essentially a search problem, because there are more possible mixtures than anyone could ever test, and none of them can be predicted in advance. As a result, bringing a single formulation to market today takes three to five years of trial and error in a lab. Our models predict how a mixture will behave far faster than the standard methods used today, which lets us design new formulations in weeks rather than years, at a fraction of the cost. To prove this, we used them to invent three chemicals that never existed before, including a PFAS-free coolant for datacenters, and we have since synthesized and patented all three. We are already working with some of the largest manufacturers to design formulations for them, and we are building our own lab to generate the data that will train our next models.
    ai
    manufacturing
    deep-learning
    biotech
  • TareBio
    TareBio
    Y Combinator LogoS2026
    Active • 1 employees • San Francisco
    Our platform develops personalized or population-level vaccines for any disease in weeks by changing only one input: the immune imprint. Instead of trying to predict which antigens might work, we read out immune cells already fighting the disease in the body and reverse-engineer antigens that activate them. We've already run our platform end-to-end and created a vaccine that cured cancer in mice.
    vaccines
    synthetic-biology
    biotechnology
  • Elite
    Elite
    Y Combinator LogoS2026
    Active • 2 employees • San Francisco
    Elite builds AI voice agents that run the front office for healthcare practices. Elite answers every patient call instantly and finishes the job inside the practice's EHR: scheduling, triage, referrals, refills, eligibility, intake, and billing, across voice, SMS, and web, around the clock. Front offices are drowning in phone volume, so patients wait on hold, calls go unanswered, and staff get pulled away from care. Elite picks up every call, resolves the routine ones end to end, and escalates anything complex to the team with full context. It ships knowing the scheduling protocols of 18 specialties and writes back to more than 19 EHRs including Epic, athenahealth, eClinicalWorks, and ModMed. There is no rip-and-replace, it goes live in days, and every resolved patient interaction is what we charge for. Our starting point is healthcare. The mission is to rebuild the critical industries America runs on, including government, finance, insurance, and manufacturing, by deploying AI agents into the slow, manual workflows at their core.
    ai
    healthcare
  • Gutgutgoose
    Gutgutgoose
    Y Combinator LogoS2026
    Active • 7 employees • San Francisco
    Most data companies pay for their data. Ours pays for itself. Customers send us a stool sample. We sequence it, build a metabolic model of that gut, and simulate whether each probiotic strain has an open niche it can colonize. We formulate the best candidates, then re-sequence 90 days later to see what actually took hold and what changed. Each cycle gives us the baseline gut, the intervention, and the outcome. At scale, the endgame is models that predict chronic disease years before symptoms.
    personalization
    health-&-wellness
    biotech
    consumer
  • Lumeria
    Lumeria
    Y Combinator LogoS2026
    Active • 3 employees • San Francisco
    The Lumoscope is a multispectral camera that clips onto your phone and scans your skin at home with the same light used in clinics. You see what a mirror can't: a breakout days before it surfaces, and wrinkles changing over time. Our software then reads that history, connects flare-ups to causes you'd never suspect, and matches products to what your own data shows works.
    consumer-health-services
    skincare
    health-&-wellness
    health-tech
    ai
  • RonanRx Inc.
    RonanRx Inc.
    Y Combinator LogoS2026
    Active • 5 employees • San Francisco
    RonanRX is a full-stack pharmaceutical company, starting with personalized peptides and GLP-1s. In our first 10 weeks, we went from having no pharmacy to being licensed in 33 states. Since launch, we’ve grown 50% week over week. We manufacture the medications ourselves, sell directly to patients, and eliminate the layers of middlemen that make prescription drugs more expensive. What makes this possible is AI. Traditional pharmaceutical companies are built to manufacture one drug for millions of people. RonanRX is purpose-built to personalize treatment for each patient: different biology, different response, different dose. Patients come directly to RonanRX or through doctors using our platform. Every patient completes our medical intake, meets with a licensed doctor through our telehealth platform, and receives a personalized prescription when appropriate. From there, we manufacture the medication ourselves and deliver it directly to the patient. Labs, wearables, medical history, treatment response, and other health data feed back into the platform so doctors can continuously refine treatment over time. Before AI, doing this for every patient at scale was impossible. We didn't invent the demand we are seeing. 80 Million people are on a GLP-1 and millions more are using Peptides. We're building a better way to manufacture, personalize, prescribe, and deliver them. Our founders have built and exited multiple companies, raised more than $100M, built a $50M U.S. medical manufacturing business, and spent years developing peptide therapeutics at companies including Eli Lilly and AbbVie. We’re just getting started with peptides and GLP-1s. Next comes hormone therapy and the rest of personalized medicine.
    telehealth
    health-tech
    therapeutics
  • Avoca Systems
    Avoca Systems
    Y Combinator LogoS2026
    Active • 6 employees • San Francisco
    Avoca is the AI patient access platform built for radiology. It integrates with a network’s existing systems and operational knowledge to automate calls, online scheduling, faxes, e-referrals and patient communications, from referral through to results and follow-up. Unlike generic scheduling tools, Avoca understands the clinical, operational and resource constraints behind every radiology booking, helping providers capture more demand, reduce administrative work and fill more scan capacity.
    healthcare
    healthcare-it
    enterprise-software
  • Gamgee
    Gamgee
    Y Combinator LogoS2026
    Active • 2 employees • San Francisco
    ​Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring ​We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next
    genomics
    oncology
    biotech
    ai
  • Hubble
    Hubble
    Y Combinator LogoS2026
    Active • 2 employees • Seattle
    Hubble’s mission is to unify the patient medical record and remove the barriers to accessing it. Today, a person’s health history is scattered across disconnected systems, leaving patients and the people helping them to piece it together. We’re building a future where one authorization unlocks a more complete record, regardless of where someone received care. Our founders previously built healthcare and AI products at Grow Therapy and Amazon One Medical, and we’re backed by Y Combinator, Madrona, and Basis Set. We’re building our team in Seattle, with the opportunity to work directly with the founders and shape how people access and use their health information.
    healthcare
    b2b
  • Illume Labs
    Illume Labs
    Y Combinator LogoS2026
    Active • 3 employees • San Francisco
    Illume is a 24/7 AI personal health & longevity companion that connects your wearables, blood panels, and genomic data to text you personalized and actionable insights. We pull in your health data and fuse it into one secure model. You get daily text updates on what changed, what it means, and what to do next; conversational health Q&A like "What should I do to improve my bloodwork?"; cross-data trend detection that catches patterns individual platforms miss; and a full platform to dig deeper, explore your health data, and text your Illume agent anytime. We're 3 MIT grads & friends, with experience at Windsurf, MIT CSAIL, Eli Lilly, & the Broad Institute.
    generative-ai
    health-&-wellness
    health-tech
    biotech
    ai
  • Floracene
    Floracene
    Y Combinator LogoS2026
    Active • 2 employees • New York City
    Floracene lets any healthcare operator describe the internal tool they need and deploy it in one click - connected to production data, with read and write access scoped by the user. Think Lovable or Retool, except purpose-built for the needs of healthcare business that has no engineering team. The bottleneck in healthcare isn't building anymore. Anyone can vibecode an 80% solution in an afternoon, custom to their own workflow, with people already on staff. The tool then dies locally on the builder’s computer, because IT (correctly) won't let anyone deploy a tool touching PHI without first-class authentication and permissioning. Our first customer had multiple employees who had each built useful tools and dashboards locally, but couldn’t actually share these with coworkers or connect to their core practice data. Within weeks of implementing Floracene, they were able to consolidate their BI tooling into Floracene and shipped 4 net-new to production. A staggering ~$200B is spent on administrative software in healthcare every year in the US. Tens of thousands of those companies still run core operations on spreadsheets, and we're at the top of the first inning of AI adoption. Asaph and Jonah met on the hospitals team at Palantir two years ago, and have each spent the last four years in the plumbing of US healthcare: claims, eligibility, and payor contracting. Asaph was an early PM at Garner. Jonah was a founding engineer at Metriport (YC S22) after starting his own fax-automation startup for fertility clinics.
    medical-devices
    healthcare-it
    digital-health
    enterprise-software
    health-tech
  • Insurf
    Insurf
    Y Combinator LogoS2026
    Active • 3 employees • Providence, RI, USA
    Insurf is the AI-native data and decision layer for health insurance. Our model Surely identifies the lowest-cost coverage for anyone, saving individuals, families, and companies thousands per employee. Our product Inveto collects the data from hospitals and clinics that informs Surely.
    automation
    health-tech
    ai
    healthcare
    insurance
  • Cova
    Cova
    Y Combinator LogoS2026
    Active • 2 employees • New York City
    Millions of Americans already care for someone they love. We're building a world where they can get paid for it, with the technology to make the process simple, the support to help them provide better care, and a model that gives more back to those doing the real work.
    healthcare
    consumer-health-services
    ai
  • Prescience, Inc.
    Prescience, Inc.
    Y Combinator LogoS2026
    Active • 5 employees • San Francisco
    Prescience is the preeminent health benefits platform for the world's most ambitious companies. We save employers 20-50% on health insurance while offering best-in-industry health benefits: www.getprescience.com About us: Prescience is building a new healthcare system for America. We train AI systems to: create, operate, insure, and deliver healthcare for employer health plans. Prescience Time Machine – an AlphaGo-like system – steers patients towards “Move 37 health trajectories” that deliver dramatic cost savings for employers. Rishab Jain and Aditya Jain, M.D. are serial entrepreneurs and brothers from Harvard & Harvard Medical School with backgrounds in machine learning and medicine. We believe abundant intelligence will bring an opportunity to fundamentally rebuild the $4.5T healthcare industry around proactive (prescient) health and wellness.
    b2b
    health-insurance
    insurance
  • Care GP
    Care GP
    Y Combinator LogoW2027
    Active • 10 employees • Sydney NSW, Australia
    Care GP is building AI agents to run operations for primary healthcare clinics
    ai
    healthcare
    saas
  • Plena Health
    Plena Health
    Y Combinator LogoP2026
    Active • San Francisco
    Plena is the AI operating system for specialty medical practices. We automate the administrative workflows that keep clinics running — referrals, fax intake, scheduling, procedure compliance, and collections — end to end, across all the systems a practice already uses. Unlike point solutions that cover a slice of the problem, Plena becomes the operating layer across the entire practice, connecting the systems, teams, and workflows that keep it running. In 10 months we've grown 17x and crossed seven figures in committed ARR across six specialties and eight states, with 80% of growth through word of mouth.
  • Infera
    Infera
    Y Combinator LogoP2026
    Active • 2 employees • San Francisco
    Describe an experiment in plain English, and Infera turns it into a validated, instrument-ready run across the equipment your lab already uses. Infera handles the protocol logic, vendor-specific scripts, data, inventory, and institutional knowledge in one system. An AI-native compiler for the lab: one system from intent to execution.
    ai
    biotech
    automation
    b2b
    saas
  • Lattice Health
    Lattice Health
    Y Combinator LogoP2026
    Active • 1 employees • San Francisco
    Lattice Health monitors deployed medical imaging AI so hospitals can tell whether each model is still working, tracking agreement with the radiologist's read, drift, and performance across patient groups. It observes rather than controls and produces the evidence teams need for safety, governance and compliance.
    healthcare-it
    healthcare
  • Voquill
    Voquill
    Y Combinator LogoP2026
    Active • 3 employees • San Francisco
    Voquill is the modern AI-native operating system for medical labs. This software manages the entire workflow of the lab (accessioning, workflow, reporting, coding, compliance, and revenue) and contains modern agentic AI tools to help each step. For example, pathologists can write reports 20% faster through our voice AI coworker. Incumbent lab operating systems are old, don't scale with how modern labs work, and can’t integrate existing AI solutions. As a result, labs are either building their own or paying millions for band-aid solutions and consultants. We're building an agentic platform to manage every aspect of the lab and displace the billions spent on legacy management systems.
  • Panacea
    Panacea
    Y Combinator LogoP2026
    Active • 3 employees • San Francisco
    Panacea provides AI-native FDA regulatory services for Biotechs and Medical Device companies. We hire the most experienced FDA consultants in the industry (ex-FDA, decades of experience, hundreds of filings) and pair them with our AI platform to enable the fastest and lowest cost pathway to FDA approval. While other regulatory consultants bill hourly, our pricing model is simple: fixed, outcome-based pricing. Payment is only due when milestones are complete. We support all FDA regulatory pathways including IND, NDA, BLA, ODD, Pre-Subs, 510(k), De Novo, PMA, IDE, BDD, etc.
  • AbInitio Bio
    AbInitio Bio
    Y Combinator LogoP2026
    Active • 2 employees • Boston
    Abinitio Bio builds foundation models for biomanufacturing, validated against wet lab data. Our first model, Echo, predicts manufacturing outcomes more accurately than standard models, and any pharma or CDMO can adapt it to their own workflow instantly. By making process decisions that take 6-18 months today in hours, we help teams avoid the cost of delay on a single program.
  • FinalDose
    FinalDose
    Y Combinator LogoP2026
    Active • 5 employees • London
    FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.
    therapeutics
    genetic-engineering
    gene-therapy
    ai
  • Arctic Health
    Arctic Health
    Y Combinator LogoP2026
    Active • 4 employees • New York City
    Arctic Health is building AI-native credentialing and contracting for healthcare organizations. We automate the full workflow, from establishing payer contracts to enrolling each provider. We collect and validate organization and provider data according to each state and payer’s requirements, and submit on the organization's behalf. We then monitor status and compliance on an ongoing basis. Tools on the market today either perform small pieces of the workflow or price out small and mid-sized organizations. We handle the process end-to-end regardless of organization type or size. Our browser automations enable AI agents to submit and monitor across hundreds of payer portals, and our system is trained by experienced industry experts who handle every edge case. Healthcare organizations get one simple platform. We handle the rest.
  • Klarify
    Klarify
    Y Combinator LogoP2026
    Active • 3 employees • Toronto, ON, Canada
    Klarify handles every job a therapist does other than the therapy itself, from clinical notes and treatment plans to insurance claims and finding new clients. Therapists hold the world together. They also run businesses, file insurance claims, write letters, fill forms, supervise new grads, and do hours of paperwork every night. Practice management software has existed for decades. It records what therapists do. It can't actually do any of it. Klara is the AI at the heart of Klarify. She handles notes, treatment plans, clinical letters, insurance claims, between-session resources, supervision prep, and finding new clients. Nearly 12,300 therapists use Klarify today. Our mission is to empower therapists, not replace them. So they can focus on the one thing only a human can do. Be present with their client.
  • Juno
    Juno
    Y Combinator LogoP2026
    Active • 5 employees • London
    Juno is an AI personal health assistant for the 1B+ people living with chronic illness. Launched in October, Juno now supports 300,000+ patients globally.
  • Framewise Health
    Framewise Health
    Y Combinator LogoP2026
    Active • 2 employees • San Francisco
    We turn medical records into personalized videos walking patients through onboarding, adherence, and recovery. The engagement data we collect builds our AI-native patient engagement platform for pharma, hospitals, medical devices, and private clinics, so they can stop chasing the patient and spend more time caring for them.
  • Taiga
    Taiga
    Y Combinator LogoP2026
    Active • 2 employees • San Francisco
    Taiga automates medical billing for doctor's offices. A doctor uploads their visit data, our AI figures out the right billing codes, checks the claim for errors, and submits it to insurance, dealing with any denials. Faster billing, fewer rejected claims, less busywork. We're Nanda and Adam, friends since 3rd grade. Both of our parents are doctors with their own practices, and billing was always a source of stress and lost revenue for them. We want providers to treat patients while we handle the rest.
Loading more companies...